Home/Filings/4/0000904454-16-001527
4//SEC Filing

Tobira Therapeutics, Inc. 4

Accession 0000904454-16-001527

CIK 0001311596operating

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 9:42 PM ET

Size

11.0 KB

Accession

0000904454-16-001527

Insider Transaction Report

Form 4
Period: 2016-11-01
Transactions
  • Disposition from Tender

    Common Stock

    2016-11-01$28.35/sh285,679$8,099,0000 total
Transactions
  • Disposition from Tender

    Common Stock

    2016-11-01$28.35/sh285,679$8,099,0000 total
BLAIR JAMES C
10% Owner
Transactions
  • Disposition from Tender

    Common Stock

    2016-11-01$28.35/sh285,679$8,099,0000 total
DOVEY BRIAN H
10% Owner
Transactions
  • Disposition from Tender

    Common Stock

    2016-11-01$28.35/sh285,679$8,099,0000 total
TREU JESSE I
Director10% Owner
Transactions
  • Disposition from Tender

    Common Stock

    2016-11-01$28.35/sh285,679$8,099,0000 total
Footnotes (2)
  • [F1]The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of One Palmer Square Associates VI, LLC, the sole general partner of the designated Reporting Person. Pursuant to Instruction 4(b)(iv) of Form 4, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.
  • [F2]Pursuant to the terms of a merger agreement, pursuant to which the Issuer was acquired by Allergan Holdco US, Inc., the shares were tendered for $28.35 per share in cash plus one non-transferable contingent value right per share, which represents the contractual right to receive one or more payments in cash of up to $49.84 per share in the aggregate, contingent upon the achievement of certain milestones.

Issuer

Tobira Therapeutics, Inc.

CIK 0001311596

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311596

Filing Metadata

Form type
4
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 9:42 PM ET
Size
11.0 KB